FIM
GSK icon

Foresters Investment Management’s GSK GSK Stock Holding History

Foresters Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$5.6M Hold
105,040
– – 0.11% 239
2019
Q2 		$5.25M Hold
105,040
– – 0.09% 266
2019
Q1 		$5.49M Buy
105,040
+22,840
+28% +$1.14M 0.1% 267
2018
Q4 		$3.93M Sell
82,200
-800
-1% -$39.4K 0.07% 292
2018
Q3 		$4.17M Sell
83,000
-6,480
-7% -$329K 0.07% 316
2018
Q2 		$4.51M Buy
89,480
+32,880
+58% +$1.66M 0.08% 282
2018
Q1 		$2.76M Hold
56,600
– – 0.05% 307
2017
Q4 		$2.51M Buy
56,600
+400
+0.7% +$18.5K 0.04% 317
2017
Q3 		$2.85M Buy
56,200
+560
+1% +$28.4K 0.05% 293
2017
Q2 		$3M Sell
55,640
-640
-1% -$34.1K 0.05% 293
2017
Q1 		$2.97M Buy
56,280
+960
+2% +$48.7K 0.05% 272
2016
Q4 		$2.65M Buy
55,320
+640
+1% +$31.6K 0.05% 283
2016
Q3 		$2.95M Buy
54,680
+640
+1% +$35.1K 0.05% 268
2016
Q2 		$2.93M Buy
54,040
+4,080
+8% +$215K 0.06% 267
2016
Q1 		$2.53M Hold
49,960
– – 0.05% 263
2015
Q4 		$2.52M Hold
49,960
– – 0.05% 262
2015
Q3 		$2.4M Hold
49,960
– – 0.05% 268
2015
Q2 		$2.6M Buy
49,960
+8,040
+19% +$453K 0.05% 276
2015
Q1 		$2.42M Buy
41,920
+8,000
+24% +$459K 0.05% 266
2014
Q4 		$1.81M Sell
33,920
-12,000
-26% -$671K 0.04% 265
2014
Q3 		$2.64M Sell
45,920
-8,000
-15% -$490K 0.06% 241
2014
Q2 		$3.6M Hold
53,920
– – 0.07% 230
2014
Q1 		$3.6M Hold
53,920
– – 0.08% 232
2013
Q4 		$3.6M Hold
53,920
– – 0.08% 221
2013
Q3 		$3.38M Sell
53,920
-16,000
-23% -$1.03M 0.08% 214
2013
Q2 		$4.37M Buy
+69,920
New +$4.44M 0.13% 160

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Foresters Investment Management's GSK Position: Q3 2019 in Review

Foresters Investment Management held its GSK (GSK) position steady in Q3 2019 at 105,040 shares worth $5.6M. The position accounts for 0.11% of the portfolio, ranked #239.

Foresters Investment Management first reported a position in GSK in Q2 2013 and has held it in 26 quarters since. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Foresters Investment Management held 105,040 shares of GSK worth $5.6M as of Q3 2019.
  • Foresters Investment Management left its GSK share count unchanged in Q3 2019.
  • GSK made up 0.11% of Foresters Investment Management's portfolio in Q3 2019, its #239 holding.
  • Foresters Investment Management first reported a position in GSK in Q2 2013 and has held it in 26 quarters since.
  • 805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Foresters Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.